UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

The UCLA Division of Plastic & Reconstructive Surgery


Andrew Da Lio, MD

Andrew L. Da Lio, MD, FACS
Clinical Professor & Chief

Dr. Da Lio's research focuses on microsurgery, objective assessment of abdominal wall function after free TRAM flap breast reconstruction, the use of nuclear medicine imaging (FDG-PET scanning) in differentiating benign and malignant lesions after breast reconstruction, and the role of decision analysis in breast reconstruction surgery.

These clinical outcomes studies utilize data drawn from the operative volume generated by UCLA and databases developed by the Department of Health and Human Services in order to analyze treatment guidelines, procedures, complications, and outcomes for a variety of plastic surgical procedures, including complex microsurgical flaps as well as more routine general plastic surgical cases. 

The goal of these studies is to document the correlation between medical center volumes and patient outcomes.

Clinical Outcomes Studies:

  • DEIP vs MSFT vs FT:
    Does inclusion of muscle/more perforators confer radio-protection. It is well known that radiation has adverse effects on breast free flaps.  We are looking at whether blood flow determines the level of contraction of a flap post radiation.
  • Success rates in secondary and tertiary free flap salvage rates: 
    This study will help us guide whether it is necessary to continue to try to salvage flaps after they have been compromised.  It is study of cost efficiency and patient safety.
  • Fatigue and microsurgical careers:
    We are assessing factors in the longevity of microsurgal careers.
  • Breast reconstruction in the obese patient:
    This study will help us determine whether it is safer to delay reconstruction in the obese patient.

Clinical Trials:

Recent Publications:


Phone: (310) 206-7521
Fax: (310) 206-7579

UCLA Rated One of the Top Hospitals in the Nation